vs
CAMDEN NATIONAL CORP（CAC）与STEM, INC.（STEM）财务数据对比。点击上方公司名可切换其他公司
CAMDEN NATIONAL CORP的季度营收约是STEM, INC.的1.4倍（$64.3M vs $47.1M），CAMDEN NATIONAL CORP净利率更高（34.0% vs -33.9%，领先67.9%），过去两年STEM, INC.的营收复合增速更高（36.1% vs 22.6%）
卡姆登国民银行是一家总部位于美国缅因州卡姆登的商业银行，是上市银行控股公司卡姆登国民集团的核心子公司。该行创立于1875年，1984年完成企业重组后成为控股公司直接持有的全资子公司。2025年与诺斯韦金融合并后，合并后机构总资产约为70亿美元。
该公司是一家公开上市的生物制药企业，总部位于加利福尼亚州纽瓦克，专注研发纯化人类神经干细胞，旨在治疗中枢神经系统疾病与瘫痪，其所研发的神经干细胞可分化为中枢神经系统的神经元、星形胶质细胞与少突胶质细胞这三大主要细胞类型。
CAC vs STEM — 直观对比
营收规模更大
CAC
是对方的1.4倍
$47.1M
净利率更高
CAC
高出67.9%
-33.9%
两年增速更快
STEM
近两年复合增速
22.6%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $64.3M | $47.1M |
| 净利润 | $21.9M | $-16.0M |
| 毛利率 | — | 48.9% |
| 营业利润率 | — | -17.7% |
| 净利率 | 34.0% | -33.9% |
| 营收同比 | — | -15.6% |
| 净利润同比 | — | 68.8% |
| 每股收益（稀释后） | $1.29 | $-4.40 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CACSTEM
| Q1 26 | $64.3M | — | ||
| Q4 25 | $68.1M | $47.1M | ||
| Q3 25 | $65.4M | $38.2M | ||
| Q2 25 | $62.3M | $38.4M | ||
| Q1 25 | $60.1M | $32.5M | ||
| Q4 24 | $47.6M | $55.8M | ||
| Q3 24 | $45.0M | $29.3M | ||
| Q2 24 | $42.8M | $34.0M |
净利润CACSTEM
| Q1 26 | $21.9M | — | ||
| Q4 25 | $22.6M | $-16.0M | ||
| Q3 25 | $21.2M | $-23.8M | ||
| Q2 25 | $14.1M | $202.5M | ||
| Q1 25 | $7.3M | $-25.0M | ||
| Q4 24 | $14.7M | $-51.1M | ||
| Q3 24 | $13.1M | $-148.3M | ||
| Q2 24 | $12.0M | $-582.3M |
毛利率CACSTEM
| Q1 26 | — | — | ||
| Q4 25 | — | 48.9% | ||
| Q3 25 | — | 35.5% | ||
| Q2 25 | — | 33.4% | ||
| Q1 25 | — | 32.4% | ||
| Q4 24 | — | -4.4% | ||
| Q3 24 | — | 21.2% | ||
| Q2 24 | — | 27.6% |
营业利润率CACSTEM
| Q1 26 | — | — | ||
| Q4 25 | 41.5% | -17.7% | ||
| Q3 25 | 40.5% | -33.6% | ||
| Q2 25 | 28.5% | -34.8% | ||
| Q1 25 | 10.3% | -65.0% | ||
| Q4 24 | 38.7% | -84.4% | ||
| Q3 24 | 35.2% | -493.2% | ||
| Q2 24 | 34.7% | -1705.5% |
净利率CACSTEM
| Q1 26 | 34.0% | — | ||
| Q4 25 | 33.1% | -33.9% | ||
| Q3 25 | 32.4% | -62.2% | ||
| Q2 25 | 22.6% | 527.8% | ||
| Q1 25 | 12.2% | -76.9% | ||
| Q4 24 | 30.8% | -91.6% | ||
| Q3 24 | 29.1% | -506.3% | ||
| Q2 24 | 28.0% | -1712.6% |
每股收益（稀释后）CACSTEM
| Q1 26 | $1.29 | — | ||
| Q4 25 | $1.33 | $-4.40 | ||
| Q3 25 | $1.25 | $-2.84 | ||
| Q2 25 | $0.83 | $-1.79 | ||
| Q1 25 | $0.43 | $-0.15 | ||
| Q4 24 | $1.00 | $-15.29 | ||
| Q3 24 | $0.90 | $-18.24 | ||
| Q2 24 | $0.81 | $-71.81 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $48.9M |
| 总债务越低越好 | $514.4M | — |
| 股东权益账面价值 | $710.0M | $-249.4M |
| 总资产 | $7.0B | $308.9M |
| 负债/权益比越低杠杆越低 | 0.72× | — |
8季度趋势，按日历期对齐
现金及短期投资CACSTEM
| Q1 26 | — | — | ||
| Q4 25 | — | $48.9M | ||
| Q3 25 | — | $43.1M | ||
| Q2 25 | — | $40.8M | ||
| Q1 25 | — | $58.6M | ||
| Q4 24 | — | $56.3M | ||
| Q3 24 | — | $75.4M | ||
| Q2 24 | — | $89.6M |
总债务CACSTEM
| Q1 26 | $514.4M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益CACSTEM
| Q1 26 | $710.0M | — | ||
| Q4 25 | $696.6M | $-249.4M | ||
| Q3 25 | $676.4M | $-235.7M | ||
| Q2 25 | $652.1M | $-214.1M | ||
| Q1 25 | $640.1M | $-417.5M | ||
| Q4 24 | $531.2M | $-398.4M | ||
| Q3 24 | $529.9M | $-344.1M | ||
| Q2 24 | $508.3M | $-203.2M |
总资产CACSTEM
| Q1 26 | $7.0B | — | ||
| Q4 25 | $7.0B | $308.9M | ||
| Q3 25 | $7.0B | $362.6M | ||
| Q2 25 | $6.9B | $379.2M | ||
| Q1 25 | $7.0B | $405.1M | ||
| Q4 24 | $5.8B | $437.4M | ||
| Q3 24 | $5.7B | $537.8M | ||
| Q2 24 | $5.7B | $691.5M |
负债/权益比CACSTEM
| Q1 26 | 0.72× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $8.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CACSTEM
| Q1 26 | — | — | ||
| Q4 25 | $63.9M | $8.2M | ||
| Q3 25 | $36.1M | $11.4M | ||
| Q2 25 | $6.0M | $-21.3M | ||
| Q1 25 | $1.0M | $8.5M | ||
| Q4 24 | $60.9M | $-14.7M | ||
| Q3 24 | $-14.5M | $-9.4M | ||
| Q2 24 | $14.5M | $-11.9M |
自由现金流CACSTEM
| Q1 26 | — | — | ||
| Q4 25 | $58.2M | — | ||
| Q3 25 | $35.4M | — | ||
| Q2 25 | $4.5M | — | ||
| Q1 25 | $-727.0K | — | ||
| Q4 24 | $55.4M | — | ||
| Q3 24 | $-16.2M | — | ||
| Q2 24 | $13.2M | — |
自由现金流率CACSTEM
| Q1 26 | — | — | ||
| Q4 25 | 85.5% | — | ||
| Q3 25 | 54.1% | — | ||
| Q2 25 | 7.3% | — | ||
| Q1 25 | -1.2% | — | ||
| Q4 24 | 116.4% | — | ||
| Q3 24 | -36.0% | — | ||
| Q2 24 | 30.8% | — |
资本支出强度CACSTEM
| Q1 26 | — | — | ||
| Q4 25 | 8.4% | — | ||
| Q3 25 | 1.1% | — | ||
| Q2 25 | 2.4% | — | ||
| Q1 25 | 2.9% | — | ||
| Q4 24 | 11.7% | — | ||
| Q3 24 | 3.8% | — | ||
| Q2 24 | 3.0% | — |
现金转化率CACSTEM
| Q1 26 | — | — | ||
| Q4 25 | 2.83× | — | ||
| Q3 25 | 1.70× | — | ||
| Q2 25 | 0.43× | -0.11× | ||
| Q1 25 | 0.14× | — | ||
| Q4 24 | 4.15× | — | ||
| Q3 24 | -1.11× | — | ||
| Q2 24 | 1.21× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CAC
| Net Interest Income | $52.4M | 81% |
| Noninterest Income | $12.0M | 19% |
STEM
暂无分部数据
